SLC5A2 and diabetes mellitus: Furthermore, there is recent evidence that SGLT2 inhibitors restore diabetes-induced metabolic perturbations via suppression of mTORC1 signaling in proximal tubular cells in young individuals with type 2 diabetes and in a diabetes mouse model (19).